Sahar Bajis

1.4k total citations
31 papers, 803 citations indexed

About

Sahar Bajis is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Sahar Bajis has authored 31 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hepatology, 20 papers in Epidemiology and 5 papers in Infectious Diseases. Recurrent topics in Sahar Bajis's work include Hepatitis C virus research (22 papers), Hepatitis B Virus Studies (13 papers) and HIV, Drug Use, Sexual Risk (8 papers). Sahar Bajis is often cited by papers focused on Hepatitis C virus research (22 papers), Hepatitis B Virus Studies (13 papers) and HIV, Drug Use, Sexual Risk (8 papers). Sahar Bajis collaborates with scholars based in Australia, United Kingdom and United States. Sahar Bajis's co-authors include Gregory J. Dore, Jason Grebely, Behzad Hajarizadeh, Evan B. Cunningham, Lisa Maher, Tanya Applegate, Marianne Martinello, Alison D. Marshall, F. Lamoury and Julie Smith and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Microbiology Reviews.

In The Last Decade

Sahar Bajis

29 papers receiving 790 citations

Peers

Sahar Bajis
Megan Crane Australia
Sheila Cameron United Kingdom
Mehlika Toy United States
Monina Klevens United States
Sahar Bajis
Citations per year, relative to Sahar Bajis Sahar Bajis (= 1×) peers Erika Duffell

Countries citing papers authored by Sahar Bajis

Since Specialization
Citations

This map shows the geographic impact of Sahar Bajis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sahar Bajis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sahar Bajis more than expected).

Fields of papers citing papers by Sahar Bajis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sahar Bajis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sahar Bajis. The network helps show where Sahar Bajis may publish in the future.

Co-authorship network of co-authors of Sahar Bajis

This figure shows the co-authorship network connecting the top 25 collaborators of Sahar Bajis. A scholar is included among the top collaborators of Sahar Bajis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sahar Bajis. Sahar Bajis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Okamoto, Emi, et al.. (2026). How to test for hepatitis D virus infection: evidence and rationale to inform policy recommendations and future directions. ˜The œLancet. Gastroenterology & hepatology. 1 indexed citations
2.
Bajis, Sahar, et al.. (2026). Who to test and reflex testing for hepatitis D virus infection: evidence and rationale to inform policy recommendations and future directions. ˜The œLancet. Gastroenterology & hepatology. 1 indexed citations
3.
Mballa, Georges Alain Etoundi, Bernhard Kerschberger, Mathurin Kowo, et al.. (2025). Assessing hepatitis C self-testing within differentiated care models in Cameroon: Feasibility, acceptability, and linkage to care for key and priority populations. PLOS Global Public Health. 5(12). e0005423–e0005423.
4.
Easterbrook, Philippa, et al.. (2024). WHO 2024 hepatitis B guidelines: an opportunity to transform care. ˜The œLancet. Gastroenterology & hepatology. 9(6). 493–495. 29 indexed citations
5.
Levinsson, Anna, Nadine Kronfli, Mathieu Maheu‐Giroux, et al.. (2024). Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysis. EClinicalMedicine. 72. 102596–102596. 8 indexed citations
6.
Cheng, Qinglu, Sahar Bajis, Evan B. Cunningham, et al.. (2023). Health-related quality of life among people who inject drugs in Australia. Quality of Life Research. 32(11). 3195–3207. 3 indexed citations
8.
Cunningham, Evan B., Alice Wheeler, Behzad Hajarizadeh, et al.. (2022). Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis. International Journal of Drug Policy. 111. 103917–103917. 31 indexed citations
9.
Hajarizadeh, Behzad, Sahar Bajis, Matthew Law, et al.. (2022). Risk of hepatitis C reinfection following successful therapy among people living with HIV: a global systematic review, meta-analysis, and meta-regression. The Lancet HIV. 9(6). e414–e427. 28 indexed citations
11.
Dore, Gregory J. & Sahar Bajis. (2021). Author Correction: Hepatitis C virus elimination: laying the foundation for achieving 2030 targets. Nature Reviews Gastroenterology & Hepatology. 18(2). 143–143. 1 indexed citations
12.
Dore, Gregory J. & Sahar Bajis. (2020). Hepatitis C virus elimination: laying the foundation for achieving 2030 targets. Nature Reviews Gastroenterology & Hepatology. 18(2). 91–92. 33 indexed citations
13.
Martinello, Marianne, Sahar Bajis, & Gregory J. Dore. (2020). Progress Toward Hepatitis C Virus Elimination. Gastroenterology Clinics of North America. 49(2). 253–277. 9 indexed citations
14.
Catlett, Beth, F. Lamoury, Sahar Bajis, et al.. (2019). Evaluation of a hepatitis C virus core antigen assay from venepuncture and dried blood spot collected samples: A cohort study. Journal of Viral Hepatitis. 26(12). 1423–1430. 13 indexed citations
15.
Bajis, Sahar, Lisa Maher, Carla Treloar, et al.. (2018). Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia. International Journal of Drug Policy. 61. 23–30. 60 indexed citations
16.
Lamoury, F., Sahar Bajis, Behzad Hajarizadeh, et al.. (2018). Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care Assay. The Journal of Infectious Diseases. 217(12). 1889–1896. 94 indexed citations
17.
Bajis, Sahar, Gregory J. Dore, Behzad Hajarizadeh, et al.. (2017). Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review. International Journal of Drug Policy. 47. 34–46. 149 indexed citations
18.
Grebely, Jason, F. Lamoury, Behzad Hajarizadeh, et al.. (2017). Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study. ˜The œLancet. Gastroenterology & hepatology. 2(7). 514–520. 105 indexed citations
19.
Bajis, Sahar, F. Lamoury, Tanya Applegate, et al.. (2017). P4 Acceptability of point of care finger-stick and venepuncture hepatitis C virus testing among people who inject drugs and homeless people. Journal of Virus Eradication. 3. 13–14. 1 indexed citations
20.
Bajis, Sahar, et al.. (2014). Antibiotic use in a district hospital in Kabul, Afghanistan: are we overprescribing?. Public Health Action. 4(4). 259–264. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026